This protein family is endemic to Kinetoplastids, might have emerged de novo and also expanded. . The family also contains Leishmaniid members lacking the signal peptide and only having an MTTPA- start sequence
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 9 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: E9AMD8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 119 | 123 | PF00656 | 0.623 |
CLV_C14_Caspase3-7 | 132 | 136 | PF00656 | 0.681 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 155 | 157 | PF00675 | 0.420 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.410 |
CLV_PCSK_FUR_1 | 99 | 103 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.620 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.414 |
DEG_MDM2_SWIB_1 | 34 | 42 | PF02201 | 0.382 |
DEG_SCF_FBW7_1 | 1 | 7 | PF00400 | 0.409 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.458 |
DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.724 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.402 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 29 | 33 | PF00917 | 0.418 |
LIG_14-3-3_CanoR_1 | 109 | 113 | PF00244 | 0.697 |
LIG_14-3-3_CanoR_1 | 23 | 29 | PF00244 | 0.342 |
LIG_14-3-3_CterR_2 | 161 | 165 | PF00244 | 0.660 |
LIG_BRCT_BRCA1_1 | 29 | 33 | PF00533 | 0.360 |
LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.549 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.652 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.295 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.266 |
LIG_FHA_2 | 136 | 142 | PF00498 | 0.642 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.429 |
LIG_HCF-1_HBM_1 | 144 | 147 | PF13415 | 0.591 |
LIG_HCF-1_HBM_1 | 77 | 80 | PF13415 | 0.546 |
LIG_LIR_Gen_1 | 51 | 60 | PF02991 | 0.223 |
LIG_LIR_Nem_3 | 144 | 150 | PF02991 | 0.650 |
LIG_LIR_Nem_3 | 36 | 42 | PF02991 | 0.307 |
LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.201 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.653 |
LIG_MLH1_MIPbox_1 | 82 | 86 | PF16413 | 0.549 |
LIG_Pex14_2 | 34 | 38 | PF04695 | 0.409 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.235 |
LIG_SH2_PTP2 | 147 | 150 | PF00017 | 0.635 |
LIG_SH2_PTP2 | 53 | 56 | PF00017 | 0.398 |
LIG_SH2_STAT3 | 66 | 69 | PF00017 | 0.652 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.635 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.683 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.464 |
LIG_SUMO_SIM_anti_2 | 40 | 46 | PF11976 | 0.300 |
LIG_SUMO_SIM_par_1 | 45 | 51 | PF11976 | 0.212 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.718 |
MOD_CK1_1 | 134 | 140 | PF00069 | 0.739 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.355 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.647 |
MOD_CK2_1 | 135 | 141 | PF00069 | 0.768 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.433 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.443 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.420 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.346 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.702 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.722 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.422 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.357 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.567 |
MOD_NEK2_2 | 29 | 34 | PF00069 | 0.377 |
MOD_PKA_1 | 100 | 106 | PF00069 | 0.673 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.675 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.710 |
MOD_PKB_1 | 99 | 107 | PF00069 | 0.711 |
MOD_Plk_1 | 124 | 130 | PF00069 | 0.669 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.651 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.444 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.377 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.643 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.356 |
TRG_ER_diArg_1 | 160 | 163 | PF00400 | 0.658 |
TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.682 |
TRG_NLS_MonoExtC_3 | 69 | 74 | PF00514 | 0.644 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P923 | Leptomonas seymouri | 46% | 78% |
A0A3S5H659 | Leishmania donovani | 75% | 99% |
A0A3S7WQ87 | Leishmania donovani | 32% | 100% |
A4H5C6 | Leishmania braziliensis | 37% | 100% |
A4H5C7 | Leishmania braziliensis | 56% | 100% |
A4HTK6 | Leishmania infantum | 32% | 100% |
A4HTK7 | Leishmania infantum | 76% | 99% |
E9AMD7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
Q4QIB1 | Leishmania major | 74% | 100% |
Q4QIB2 | Leishmania major | 35% | 100% |